Capitol Clarity / Firms / Coherus Biosciences

Coherus Biosciences

Coherus Biosciences lobbies on its own behalf. For Q2 2026 it reported $95K across 1 client report and lists 1 lobbyist across its filings. Issues include Government Issues and Health Issues.

Clients, Q2 2026

ClientReportedIssues
COHERUS BIOSCIENCES, INC.$95KGovernment Issues, Health Issues

By year

YearReportedClients
2026$175K1
2025$395K1

Lobbyists listed

Amounts are the filer's good-faith estimates, per report, and cannot be split by issue. See the Capitol Clarity rankings and method.